Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

Julia-Christina Stadler; Laura Keller; Christian Mess; Alexander T Bauer; Julian Koett; Glenn Geidel; Isabel Heidrich; Sabine Vidal-y-Sy; Antje Andreas; Carlotta Stramaglia; Mark Sementsov; Wiebcke Haberstroh; Benjamin Deitert; Inka Lilott Hoehne; Robin Reschke; Thomas Haalck; Klaus Pantel; Christoffer Gebhardt; Stefan W Schneider

doi:10.1136/jitc-2022-006456

Article Text

PDF

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

https://doi.org/10.1136/jitc-2022-006456

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1
Data supplement 2
Data supplement 3
Data supplement 4
Data supplement 5

Log in using your username and password

Main menu

Log in using your username and password

You are here

Statistics from Altmetric.com

Request Permissions

Supplementary materials

Supplementary Data

Read the full text or download the PDF:

Log in using your username and password